ChinaBio News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Tianyin Granted Two SFDA Approvals

publication date: Aug 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Tianyin Pharmaceutical Co. received SFDA approvals for two new products: 0.5 gram/tablet formulations of Sanqi Tablets and Yinqiao Jiedu Tablets. Sanqi is a generic TCM that treats traumatic injuries and stops bleeding without causing blood stasis, while alleviating pain and reducing swelling. Also a generic TCM, Yinqiao Jiedu is used to treat acute respiratory system ailments, such as influenza and the common cold. More details...

Stock Symbol: (NYSE AMEX: TPI)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events

SEED Finalists Coaching Day
March 2, 2010
Shanghai, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
 
Partner Events

March 8–10, 2010
Barcelona, Spain

World CRO Summit 2010
March 11-12, 2010
Shanghai, China

BIO-Europe 2010
Munich, Germany
November 15–17, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners